Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elihu Estey

Showing results (71-80 of 127) with videos related to

Pageof 13
Sort By:
Blood|October 2, 2008
Time from diagnosis to treatment initiation predicts survival in younger, but not older, acute myeloid leukemia patientsMikkael A Sekeres, Paul Elson, Matt E Kalaycio, et al.
Leukemia Research Reports|December 28, 2013
Evaluation of early discharge after hospital treatment of neutropenic fever in acute myeloid leukemia (AML)Victor Chow, Kathleen Shannon Dorcy, Ravinder Sandhu, et al.
Cancer|July 29, 2010
Intensively timed combination chemotherapy for the induction of adult patients with acute myeloid leukemia: long-term follow-up of a phase 2 studyMichael Rytting, Farhad Ravandi, Elihu Estey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 2, 2003
Phase I study of oral topotecan in hematological malignanciesMiloslav Beran, Susan O'Brien, Deborah A Thomas, et al.
Cancer|January 30, 2002
Clinical significance of plasma endostatin in acute myeloid leukemia/myelodysplastic syndromeRaymond Lai, Elihu Estey, Yu Shen, et al.
Apoptosis : an International Journal on Programmed Cell Death|October 13, 2010
XIAP antisense oligonucleotide (AEG35156) achieves target knockdown and induces apoptosis preferentially in CD34+38- cells in a phase 1/2 study of patients with relapsed/refractory AMLBing Z Carter, Duncan H Mak, Stephen J Morris, et al.
Stem Cells (Dayton, Ohio)|March 3, 2004
Engraftment of acute myeloid leukemia in NOD/SCID mice is independent of CXCR4 and predicts poor patient survivalGiuseppe Monaco, Marina Konopleva, Mark Munsell, et al.
Blood|August 4, 2007
Establishment of baseline toxicity expectations with standard frontline chemotherapy in acute myelogenous leukemiaEhab Atallah, Jorge Cortes, Susan O'Brien, et al.
Cancer|April 25, 2003
Telomerase activity is prognostic in pediatric patients with acute myeloid leukemia: comparison with adult acute myeloid leukemiaSrdan Verstovsek, Taghi Manshouri, Franklin O Smith, et al.
Blood|October 25, 2003
Relative increase in leukemia-specific DNA in peripheral blood plasma from patients with acute myeloid leukemia and myelodysplasiaAnna Rogers, Youngson Joe, Taghi Manshouri, et al.
Pageof 13

Showing results (71-80 of 127) with videos related to

Sort By:
Pageof 13
Blood|October 2, 2008
Time from diagnosis to treatment initiation predicts survival in younger, but not older, acute myeloid leukemia patientsMikkael A Sekeres, Paul Elson, Matt E Kalaycio, et al.
Leukemia Research Reports|December 28, 2013
Evaluation of early discharge after hospital treatment of neutropenic fever in acute myeloid leukemia (AML)Victor Chow, Kathleen Shannon Dorcy, Ravinder Sandhu, et al.
Cancer|July 29, 2010
Intensively timed combination chemotherapy for the induction of adult patients with acute myeloid leukemia: long-term follow-up of a phase 2 studyMichael Rytting, Farhad Ravandi, Elihu Estey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 2, 2003
Phase I study of oral topotecan in hematological malignanciesMiloslav Beran, Susan O'Brien, Deborah A Thomas, et al.
Cancer|January 30, 2002
Clinical significance of plasma endostatin in acute myeloid leukemia/myelodysplastic syndromeRaymond Lai, Elihu Estey, Yu Shen, et al.
Apoptosis : an International Journal on Programmed Cell Death|October 13, 2010
XIAP antisense oligonucleotide (AEG35156) achieves target knockdown and induces apoptosis preferentially in CD34+38- cells in a phase 1/2 study of patients with relapsed/refractory AMLBing Z Carter, Duncan H Mak, Stephen J Morris, et al.
Stem Cells (Dayton, Ohio)|March 3, 2004
Engraftment of acute myeloid leukemia in NOD/SCID mice is independent of CXCR4 and predicts poor patient survivalGiuseppe Monaco, Marina Konopleva, Mark Munsell, et al.
Blood|August 4, 2007
Establishment of baseline toxicity expectations with standard frontline chemotherapy in acute myelogenous leukemiaEhab Atallah, Jorge Cortes, Susan O'Brien, et al.
Cancer|April 25, 2003
Telomerase activity is prognostic in pediatric patients with acute myeloid leukemia: comparison with adult acute myeloid leukemiaSrdan Verstovsek, Taghi Manshouri, Franklin O Smith, et al.
Blood|October 25, 2003
Relative increase in leukemia-specific DNA in peripheral blood plasma from patients with acute myeloid leukemia and myelodysplasiaAnna Rogers, Youngson Joe, Taghi Manshouri, et al.
Pageof 13